00287YBX6 · USDInvestment Grade · A-

Abbvie Inc 3.20% 2029/11

Abbvie IncSenior Unsecured
MID PRICE
96.25
par = 100
YIELD TO MAT.
4.79%
semi-annual
COUPON
3.200%
semi-annual · fixed
MATURITY
2029-11-21
bullet · 3.55y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
3.25 y
1bp ↑ ≈ -0.033% P&L
Convexity
12.65
higher = more curvature
Years to maturity
3.55 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Invesco BulletShares 2029 Corporate Bond
Invesco
BulletShares 2029 Corporate$35.8M▲ $57K1.30%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

19/ 100Minimal footprint
Interpretation. Minimal institutional footprint, holding
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$35.8M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▼ $107K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
96,252 USD
PRICE
96.25

RFQ routing · coming soon

Security details

AWAITING ENRICHMENT
Face value
100 USD
Seniority
Senior Unsecured

Issuer curve

Abbvie · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.